PRACOH Prevention Breakdown Support Advice Guidance Disability
PRACOH
Single-center Prospective Interventional Study Evaluating a Device for Preventing Breakdown Situations in People With Disabilities and Their Primary Caregivers
1 other identifier
interventional
100
1 country
1
Brief Summary
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's primary objective set at admission, directly related to their specific needs. It is expected to improve knowledge regarding the prevention of situations of breakdown and exhaustion in the living environment of people with disabilities.
- This would improve the life and care pathways as well as the support provided to these individuals and their families and friends.
- It would limit the use of unscheduled care services in crisis situations, thereby improving the quality of care and life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 9, 2026
March 1, 2026
2.7 years
February 2, 2026
April 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's main objective set at admission, directly related to their specific needs.
The primary endpoint is the level of achievement of the patient's primary objective, defined upon admission, after a stay in the dedicated transitional care unit. This objective of the stay is defined using a 5-level GAS (Goal Attainment Scale) with 5 levels (from -2 (initial level) to +2 (level achieved beyond the objective)). The GAS is an assessment method focused on the personalisation of care or intervention objectives. It is co-constructed between the patient and the professional and reviewed by an expert trained in the GAS.
inclusion * 1 month after the stay
Secondary Outcomes (11)
Evaluate the impact of the stay in the dedicated transitional care unit by assessing whether the caregiver's primary objective has been achieved, if the caregiver participates in the study.
at the inclusion and one month after the stay
Evaluate the main factor explaining the change in the objective perceived by the patient or caregiver and that perceived by the physician.
one month after the stay
Assess changes in the patient's anxiety and depression levels following their stay in the dedicated transitional care unit.
at the inclusion and one month after the stay
Evaluate changes in the caregiver's anxiety and depression levels following their stay in the dedicated transitional care unit, if the caregiver participates in the study.
at the inclusion and one month after the stay
Evaluate changes in the perceived burden following a stay in the dedicated transitional care unit, if the caregiver participates in the study.
at the inclusion and one month after the stay
- +6 more secondary outcomes
Study Arms (1)
INTERVENTIONAL
OTHERINTERVENTIONAL
Interventions
assess the impact of the stay in the dedicated transitional care unit by evaluating whether the patient's primary objective, set at admission and directly related to heir specific needs, has been achieved.
Eligibility Criteria
You may qualify if:
- Patients:
- People with disabilities requiring a 4-week stay in a dedicated transitional care unit at POLE MPR ST HELIER
- Men or women, of legal age (over 18)
- Affiliated with a social security scheme or entitled to benefits
- Having given their free and informed consent
- Caregivers:
- Primary caregiver from the circle of a person with a disability who has agreed to participate in the study.
- Male or female, of legal age (over 18)
- Affiliated with a social security scheme or entitled to benefits
- Having given their free and informed consent
You may not qualify if:
- Patients:
- Pregnant women, women in labor, or women who are breastfeeding
- Individuals deprived of their liberty by judicial (excluding guardianship or curatorship) or administrative decision
- Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion
- Individuals in an emergency situation who are unable to give their prior consent.
- Individuals already admitted to a healthcare or social care facility for purposes other than research.
- Caregivers:
- Professional caregivers of participants with disabilities who have agreed to participate in the study.
- Pregnant women, women in labor, or women who are breastfeeding,
- Individuals deprived of their liberty by a judicial (excluding guardianship or curatorship) or administrative decision.
- Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion
- Individuals in an emergency situation who are unable to give their prior consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation Saint-Hélier
Rennes, 35043, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2026
First Posted
March 27, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 9, 2026
Record last verified: 2026-03